MRK vs TENX · P/E 33, rev $16.61B vs P/E 3.4, $24.1M cap
Merck & Company Inc (MRK) versus Tenax Therapeutics Inc (TENX) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Tenax Therapeutics Inc (TENX) is a biotechnology company listed on US.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported TENX revenue for 2026-06-30 was $0. Net income was -$33.5M. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
Not investment advice. Open the MRK and TENX stock pages for the full models.
Not investment advice.